Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined ketamine and propofol in electroconvulsive therapy of depression
IRCT138811022935N2Phase 2Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ketamine and propofol in major depressive disorder (MDD), sponsored by Kurdistan University of Medical Sciences. Started Oct 2010; status: completed.
02
Drugs
ketaminepropofol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT138811022935N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138811022935N2.